Psychedelic

New Study Challenges Cannabis Myths About Brain Health and IQ

By Cannabis Risk Manager Staff / December 24, 2024 /

Groundbreaking Study Challenges Long-Held Beliefs About Cannabis and Cognition A new study spanning 44 years and involving over 5,000 men has challenged widely-held views on cannabis use and its impact…

Magic Mushroom Strains: Do They Really Differ?

By Cannabis Risk Manager Staff / October 15, 2024 /

Recent Studies Suggest Magic Mushroom Strains May Not Be So Different in Potency The ongoing debate over the effects of various psilocybin mushroom strains has long divided both growers and…

New Jersey Senate Panel Approves Psilocybin Therapy Bill

By Cannabis Risk Manager Staff / October 8, 2024 /

New Jersey Senate Committee Advances Therapeutic Psilocybin Bill, Lawmakers Warming to Psychedelics Proposal A New Jersey Senate committee has advanced legislation that would establish a therapeutic psilocybin program, marking a…

Feds Fund $2.4M Study on Psychedelics for Meth Addiction

By / August 29, 2024 /

NIH Allocates $2.4 Million to Research Psychedelics as Treatment for Methamphetamine Use Disorder The National Institutes of Health (NIH) has announced a significant investment of $2.4 million towards studying the…

Key to Colorado’s Psychedelics Program Success: Education

By / August 22, 2024 /

Education Seen as Key to Success of Colorado’s New Psychedelics Program As Colorado gears up to issue licenses for its newly established psychedelic mushroom program, healthcare professionals who have closely…

Colorado Unveils Legal Psychedelic Mushroom Market Framework

By / August 22, 2024 /

Colorado Unveils Legal Framework for Psychedelic Mushroom Market, Avoids Traditional Dispensary Model Colorado has officially finalized the guidelines for its legal psychedelic mushroom market, marking a significant step in the…

Top Health Official Cites Evidence of Psilocybin’s Benefits

By / August 16, 2024 /

NIH Director Highlights Growing Evidence for Psilocybin as a Potential Therapy for Mental Health Conditions Monica Bertagnolli, the Director of the National Institutes of Health (NIH), has recently highlighted the…

SXSW Opens Voting for 2025 Cannabis and Psychedelics Panels

By / August 13, 2024 /

SXSW Festival Opens Voting on Cannabis and Psychedelic Panels for 2025 The South by Southwest (SXSW) conference, renowned for its diverse and forward-thinking programming, has officially opened voting for its…

Study Shows Psilocybin’s Impact on Brain Function and Therapy

By / August 5, 2024 /

New Study Shows Psilocybin’s Profound Impact on Brain Functional Networks A recent small randomized controlled trial has revealed that a single high dose of psilocybin induces significant and persistent changes…

Students Challenge DEA’s Psychedelics Ban in Court

By / July 24, 2024 /

Exploring the Breakthrough: Quantum Computing’s Role in Revolutionizing Technology Quantum computing, a rapidly emerging field, has captured the attention of scientists, technologists, and businesses alike. Unlike classical computers, which process…

Study: Psychedelic Mushrooms Linked to Early Human Consciousness

By / July 17, 2024 /

New Study Explores Role of Psilocybin Mushrooms in Human Consciousness Evolution Buenos Aires, Argentina – A new paper delves into the potential influence of psilocybin mushrooms on the evolution of…

Mr. Cannabis Law Rebrands to Embrace Broader Services

By / July 16, 2024 /

Mr. Cannabis Law Rebrands to LumaLex Law, Expanding Expertise Beyond Cannabis and Psychedelics Mr. Cannabis Law is excited to announce its rebranding to LumaLex Law, a full-service law firm catering…